Face filler expected to soar with cases of gaunt 'Ozempic face' — and one company is cashing in

Dubbed "Ozempic face," the gaunt appearance is a growing adverse effect of the weight loss drug due to a loss of facial volume, which Flemming Ornskov, the CEO of the Swiss company Galderma, wants to solve with filler.

Related Keywords

Hollywood ,California ,United States ,New Jersey ,Switzerland ,United Kingdom ,Miami ,Florida ,Swiss ,Britain ,Scott Disick ,Sharon Osbourne ,Robbie Williams ,Flemming Ornskov ,Christopher Sadowski ,John Goodman ,Jessica Simpson ,Smita Ramanadham ,Paul Jarrod Frank ,Novo Nordisk ,Instagram ,Bloomberg ,Everyday Health ,Good Morning Britain ,Good Morning ,Daily Mail ,